login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
KALA BIO INC (KALA) Stock News
USA
- NASDAQ:KALA -
US4831192020
-
Common Stock
18.55
USD
-1.08 (-5.5%)
Last: 9/22/2025, 8:39:05 PM
18.02
USD
-0.53 (-2.86%)
Pre-Market:
9/23/2025, 8:39:54 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
KALA Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: KALA BIO, Inc.
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference
20 days ago - By: KALA BIO, Inc.
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference
21 days ago - By: KALA BIO, Inc.
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
21 days ago - By: KALA BIO, Inc.
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
a year ago - By: BusinessInsider
KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024
a year ago - By: InvestorPlace
KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024
a month ago - By: Benzinga
- Mentions:
SPY
DNA
QQQ
SNGX
...
5 Healthcare Stocks On Fire This Week
a month ago - By: Zacks Investment Research
Wall Street Analysts Believe KALA BIO (KALA) Could Rally 74.73%: Here's is How to Trade
2 months ago - By: The Motley Fool
Kala Bio (KALA) Q2 Loss Widens 15%
2 months ago - By: KALA BIO, Inc.
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2 months ago - By: KALA BIO, Inc.
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
2 months ago - By: KALA BIO, Inc.
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
2 months ago - By: KALA BIO, Inc.
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
2 months ago - By: Benzinga
- Mentions:
JHX
SOFI
HROW
JANX
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
3 months ago - By: KALA BIO, Inc.
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
3 months ago - By: KALA BIO, Inc.
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
3 months ago - By: KALA BIO, Inc.
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
4 months ago - By: KALA BIO, Inc.
KALA BIO to Present at Jefferies Global Healthcare Conference
4 months ago - By: KALA BIO, Inc.
KALA BIO to Present at Jefferies Global Healthcare Conference
4 months ago - By: KALA BIO, Inc.
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
4 months ago - By: KALA BIO, Inc.
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
6 months ago - By: KALA BIO, Inc.
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
6 months ago - By: KALA BIO, Inc.
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
7 months ago - By: KALA BIO, Inc.
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
7 months ago - By: Stocktwits
- Mentions:
VTI
VXF
ITOT
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction
7 months ago - By: KALA BIO, Inc.
KALA BIO Announces Chief Executive Officer Transition
7 months ago - By: KALA BIO, Inc.
KALA BIO Announces Chief Executive Officer Transition
9 months ago - By: KALA BIO, Inc.
KALA BIO Announces $10,750,000 Private Placement
9 months ago - By: KALA BIO, Inc.
KALA BIO Announces $10,750,000 Private Placement
10 months ago - By: KALA BIO, Inc.
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
10 months ago - By: KALA BIO, Inc.
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
11 months ago - By: KALA BIO, Inc.
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11 months ago - By: KALA BIO, Inc.
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: KALA BIO, Inc.
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
a year ago - By: KALA BIO, Inc.
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: KALA BIO, Inc.
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: KALA BIO, Inc.
KALA BIO Announces $12,500,000 Private Placement
Please enable JavaScript to continue using this application.